Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fondazione Ricerca Trapianto di Midollo Osseo (FRTMO) is an Italian non-profit research foundation dedicated to advancing the science and clinical application of bone marrow and hematopoietic stem cell transplantation. Based in Bergamo, the foundation works in close collaboration with the Hematology department of the Papa Giovanni XXIII Hospital to fund and coordinate clinical trials for blood-related cancers and disorders. Its primary mission is to improve patient outcomes by optimizing transplantation protocols, enhancing donor selection processes, and developing treatments for complications such as graft-versus-host disease. FRTMO supports translational research that bridges the gap between laboratory discoveries and bedside patient care. Through its activities, the foundation has become a key pillar in the Italian hematology research landscape, contributing to international standards in stem cell therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fondazione Ricerca Trapianto di Midollo Osseo.